Search

Background: Sertraline showed some potential in alleviating depressive disorder after traumatic brain injury. This systematic review and meta-analysis was conducted to investigate the efficacy of sertraline on the treatment of depressive disorder after traumatic brain injury.Methods: The databases including PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases were systematically searched for collecting the randomized controlled trials (RCTs) regarding the efficacy of sertraline for traumatic brain injury.Results: This meta-analysis included five RCTs. The initial use of sertraline was within 8 weeks after traumatic brain injury. Compared with control group for traumatic brain injury, sertraline treatment showed no significant improvement on Hamilton Depression Rating Scale (HAM-D) (standard mean difference (Std. MD) = -0.08; 95% confidence interval (CI) = -0.45 to 0.28; P = 0.65), anxiety score (Std. MD = 0.08; 95% CI = -0.32 to 0.48; P = 0.69), aggression score (Std. MD = -0.12; 95% CI = -0.56 to 0.32; P = 0.59), or quality of life (QOL) score (Std. MD = -0.06; 95% CI = -0.49 to 0.37; P = 0.78). There was no statistical difference of diarrhea (risk ratio (RR) = 0.85; 95% CI = 0.92 to 3.71; P = 0.08), dizziness (RR = 1.15; 95% CI = 0.57 to 2.31; P = 0.70), dry mouth (RR = 2.44; 95% CI = 0.43 to 13.89; P = 0.32), nausea or vomiting (RR = 1.17; 95% CI = 0.37 to 3.70; P = 0.79) between sertraline group and control group.Conclusions: Sertraline showed no obvious benefits for the relief of depressive disorder after traumatic brain injury. [ABSTRACT FROM AUTHOR]

Understanding oncogenic processes and underlying mechanisms to advance research into human tumors is critical for effective treatment. Studies have shown that Metal regulatory transcription factor 2（MTF2) drives malignant progression in liver cancer and glioma. However, no systematic pan-cancer analysis of MTF2 has been performed. Here, we use University of California Santa Cruz, Cancer Genome Atlas , Genotype-Tissue Expression data, Tumor Immune Estimation Resource, and Clinical Proteomic Tumor Analysis Consortium bioinformatics tools to explore differential expression of MTF2 across different tumor types. MTF2 was found to be highly expressed in the cancer lines that were available through the respective databases included in the study, and overexpression of MTF2 may lead to a poor prognosis in tumor patients such as glioblastoma multiforme, brain lower grade glioma, KIPAN, LIHC, adrenocortical carcinoma, etc. We also validated MTF2 mutations in cancer, compared MTF2 methylation levels in normal and primary tumor tissues, analyzed the association of MTF2 with the immune microenvironment, and validated the functional role of MTF2 in glioma U87 and U251 and breast cancer MDA-MB-231 cell lines by cytometry. This also indicates that MTF2 has a promising application prospect in cancer treatment. [ABSTRACT FROM AUTHOR]

Graphene is a promising material in membrane separation. However, high water permeability as well as high rejection against contaminants is still demanded yet challenging for graphene-based membranes fabrication. In this work, we synthesized an oxygen-containing group-modified reduced graphene oxide membrane (O-rGOM), which was designed by substituting the surface layers of rGO membranes with GO flakes. The number of oxygen-containing groups on membrane surface was modulated by the [GO]/[rGO] ratio during the construction of O-rGOM. Results demonstrated that a [GO]/[rGO] ratio of 1:4 was optimal, with oxygen-containing groups modifying the pore surface of rGO laminates effectively. Furthermore, the O-rGOM showed improved hydrophilicity and water permeability. In addition, modification of the oxygen-containing groups promoted the zeta potential around the membrane pore, resulting in enhanced electrostatic interaction between the membrane and charged contaminants. The O-rGOM structure exhibited 18.2% and 5.2% improvement in acid orange 7 and methylene blue rejection, respectively, as well as ∼2.6 times enhancement in water permeability compared with the rGOM. This work provides a feasible approach for the design of graphene-based membranes to improve filtration performance with enhanced water permeability. Image 1 [ABSTRACT FROM AUTHOR]

Recently, photo-Fenton technology has been widely used to degrade tetracycline (TC) because of its great efficiency and wide application range. Herein, Fe–Ni layered double hydroxides (FeNi-LDH)/Ti 3 C 2 photo-Fenton system was constructed in this study. The results showed the introduction of Ti 3 C 2 solved some problems of FeNi-LDH such as poor conductivity, easy aggregation, and high recombination rate of photoelectron. Benefiting from these advantages, FeNi-LDH/Ti 3 C 2 exhibited excellent TC removal rate of 94.7% while pure FeNi-LDH was only 54%. Besides, FeNi-LDH/Ti 3 C 2 possessed strong pH tolerance (2–11) and the removal efficiency was still up to 82% after the four-cycle experiment. Furthermore, the quenching experiments revealed the reaction mechanism, where ∙OH and ·O 2 − were the primary active radicals for degrading TC. Last, the results of the simulated wastewater treatment and the inorganic ion interference tests showed that FeNi-LDH/Ti 3 C 2 possessed practical application potential. In brief, this study shows that FeNi-LDH/Ti 3 C 2 can offer a certain theoretical basis for the actual development of hydrotalcite in heterogeneous photo-Fenton systems. [Display omitted] • A novel material FeNi-LDH/Ti 3 C 2 was successfully prepared by a facile method. • The incorporation of Ti 3 C 2 enhanced the photogenerated carrier separation. • The degradation efficiency of TC increased by 40% after introduce Ti 3 C 2. • FeNi-LDH/Ti 3 C 2 photo-Fenton system possessed great application prospect. • The possible mechanism and degradation pathways of TC were illustrated. [ABSTRACT FROM AUTHOR]

Aluminum (Al) salts are widely used as coagulants to remove phosphorus (P) in water treatment. However, the relationship between P and Al species and the underlying coagulation mechanisms is rarely studied. Currently, water eutrophication is a serious issue, and therefore advanced P removal is extremely necessary. Herein, the orthophosphate removal behavior of Al coagulants with various species distributions was investigated. The results showed that AlCl 3 ·6H 2 O (AC) had a more pronounced P removal efficiency than polyaluminum chloride (PACl). Medium (Al b or Al 13 ) and high polymeric species (Al c ) played a more significant role in removing P than monomeric species (Al a ). During coagulation, adsorption onto flocs was the dominant P removal mechanism, which could be categorized as multilayer adsorption. Although the adsorption kinetics showed that physical adsorption best described the adsorption mechanism for AC and PACl, it is worth noting that chemical adsorption also occurred during P removal by AC because of the formation of the AlPO 4 precipitate. This could be because of the strong complex adsorption between the in situ Al 13 species and P. Based on the excellent P removal performance, we believe these findings will have a large potential for application in advanced P removal in water treatment. [ABSTRACT FROM AUTHOR]